Bill Dickie, President and CEO of Advanced Accelerator Applications (AAA) Canada Inc., accepts the 2017 Industry Partner of the Year Award on behalf of IDB Holland bv, an AAA company.
IDB Holland bv is a Health Canada authorized supplier of Lutetium-177 (Lu-177). Lu-177 is a nuclear medicine treatment used to improve the quality of life in patients with neuroendocrine cancer.
With over 45 of years of philanthropic leadership, Helen and Andy Spriet have significantly advanced hospital-based research and patient care in London, Ontario. Their support of health research through the St. Joseph’s Health Care Foundation has enabled innovation and discovery in the areas of urology, mobility and aging, prostate cancer, retina disease, geriatric care, spinal cord injury and surgical mechatronics.